ProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBC
MARIETTA, Ohio--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/AAGP?src=hash" target="_blank">#AAGP</a>--ProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBC